Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience-Reference-Cited by-同舟云学术

Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience

Published:2012-01-17 Issue:1 Volume:160C Page:40-49
ISSN:1552-4868
Container-title:American Journal of Medical Genetics Part C: Seminars in Medical Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Bali Deeksha S.,Goldstein Jennifer L.,Banugaria Suhrad,Dai Jian,Mackey Joanne,Rehder Catherine,Kishnani Priya S.

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference49 articles.

1. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial;Amalfitano;Genet Med,2001

2. Two clinical forms of glycogen-storage disease type II in two generations of the same family;Amartino;Clin Genet,2006

3. Enzyme Replacement therapy for Pompe disease;Angelini;Curr Neurol Neurosci Rep.,2011

4. Homozygous deletion of exon 18 leads to degradation of the lysosomal alpha-glucosidase precursor and to the infantile form of glycogen storage disease type II;Ausems;Clin Genet,1996

5. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid alpha-glucosidase activity;Bali;Muscle Nerve,2011

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation;Molecular Genetics and Metabolism Reports;2024-12

2. Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study;International Journal of Molecular Sciences;2024-08-23

3. A Rare Case of Late Onset-Pompe’s Disease: Presented as Heart Failure;American Journal of Pediatrics;2024-08-15

4. Mutational spectrum and genotype–phenotype correlation in Mexican patients with infantile‐onset and late‐onset Pompe disease;Molecular Genetics & Genomic Medicine;2024-07

5. Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee;Cytotherapy;2024-07